跳至主要内容
临床试验/NCT03831529
NCT03831529已完成不适用

Prognostic Factors Associated With Mortality Within 6 Months Among Critically Ill Elderly Patients Admitted to the Intensive Care Unit With Severe Acute Cholangitis

Central Hospital, Nancy, France2 个研究点 分布在 1 个国家目标入组 204 人开始时间: 2018年6月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
204
试验地点
2
主要终点
mortality

研究概览

简要总结

The aging of the population goes along with an increased demand for intensive care among very elderly patients (above 75-80 years old). At the same time, there is a decline in the supply of intensive care units (ICU). The 1-year mortality of patients above 80 years old in ICU ranged from 40 to 70%. Moreover, many survivors suffer from long-term sequelae as poor quality of life, cognitive impairment and functional disability.

It is unclear under what conditions older patients may benefit from ICU admission. Cholangitis frequently occured in older patient. Moreover, severe acute cholangitis is a potentially life threatening disease characterized by a biliary obstruction and an infection of the bile possibly evolving towards systemic infection, shock and death. Because of its potential rapid reversibility of symptom thanks to early intravenous antibiotics and biliary decompression with drainage, old patients suffering from acute cholangitis are easily admitted to intensive care unit.

To date, there is a lack of data about the outcome in this population admitted to the intensive care unit with acute cholangitis.

The aim of the current study is to describe the outcomes in elderly patients (> 75 years old) admitted to the ICU with acute cholangitis and to identify prognostics factors associated with long term mortality (6 months).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • > 65 years old
  • ICU admission for acute cholangitis
  • follow up in the same center after the ICU stay

排除标准

  • 未提供

结局指标

主要结局

mortality

时间窗: 180 days

rate of survivors and non survivors

次要结局

  • mortality(28 days)
  • factors associated with 6 months mortality (underlying condition)(Day 1)
  • factors associated with 6 months mortality (severity score)(Day 1)
  • factors associated with 6 months mortality (Presence of hemodynamic failure)(Up to 7 days)
  • factors associated with 6 months mortality (Presence of respiratory failure)(Up to 7 days)
  • factors associated with 6 months mortality (Presence of renal failure)(Up to 7 days)
  • Clinical evolution(Day 3)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验